Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

Operating margins improved to 54.5%, supported by a vigilant control over expenditures, which grew by a modest 5.9%. Despite ...

Reports Q4 revenue $3.11B, consensus $3.1B. “NXP delivered full-year 2024 revenue of $12.61 billion, a decrease of 5 percent year-on-year. In ...

Reports book value and tangible book value per share of $28.66 and $24.51 at December 31, 2024, compared to $28.81 and $24.64 at September 30, ...

Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...

Revenue only grew 2 percent year over year for Tesla in Q4 2024.

The company reported C$4.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$4.16 by C$0.16. goeasy had a net margin of 33.40% and a return on equity of 25.28%.

CEO Damian Kozlowski reported Q4 EPS of $1.15 and full-year EPS of $4.29, reflecting year-over-year increases of 41% and 23%, respectively. Total revenue increased 8%, excluding $19.6 million of ...

Alliance Resource Partners LP (NASDAQ:ARLP) reported its fourth-quarter 2024 earnings, missing analyst expectations with an earnings per share (EPS) of $0.12 against a forecast of $0.70. The company's ...

Shares of AbbVie Inc. (NYSE:ABBV) surged after the company reported strong Q4 2024 results and provided in-line revenue guidance and better-than-expected EPS guidance for 2025. I am very pleased ...

For the quarter ended December 2024, Everest Group (EG) reported revenue of $4.64 billion, up 26.7% over the same period last year. EPS came in at -$18.39, compared to $25.18 in the year-ago quarter.